Tirofiban hydrochloride

This classification denotes an antiplatelet agent with the molecular formula C22H36N2O5S.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6H925F8O5J, chemically known as l-tyrosine, n-(butylsulfonyl)-o-(4-(4-piperidinyl)butyl)-, monohydrochloride, monohydrate but more generally known as tirofiban hydrochloride, which bears US NIH Compound Identifier 60946. European Medicines Agency schedules Tirofiban hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04887MIG. Most nations, for tariff and trade purposes, schedule tirofiban hydrochloride under HS 29350090 and SITC 51580. As of Q4 2014, TIROFIBAN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Tirofiban hydrochloride bears US NLM identifiers UMLS ID C0795668 and NCI Concept Code C47759. SMILES: CCCCS(=O)(=O)N[C@@H](CC1CCC(CC1)OCCCCC2CCNCC2)C(=O)O.O.CL.